AMBEY

Ambey Laboratories Share Price

₹64.80 +3.25 (5.28%)

22 Dec, 2024 22:23

SIP TrendupStart SIP in AMBEY

Start SIP

Performance

  • Low
  • ₹63
  • High
  • ₹67
  • 52 Week Low
  • ₹56
  • 52 Week High
  • ₹97
  • Open Price₹63
  • Previous Close₹62
  • Volume62,000

Investment Returns

  • Over 1 Month + 2.86%
  • Over 3 Month + 0.15%
  • Over 6 Month -4.71%
  • Over 1 Year -4.71%
SIP Lightning

Smart Investing Starts Here Start SIP with Ambey Laboratories for Steady Growth!

Invest Now

Ambey Laboratories Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • -
  • PEG Ratio
  • -
  • Market Cap Cr
  • 162
  • P/B Ratio
  • 7.7
  • Average True Range
  • 3.18
  • EPS
  • 3.19
  • Dividend Yield
  • 0
  • MACD Signal
  • 1.44
  • RSI
  • 45.72
  • MFI
  • 67.76

Ambey Laboratories Financials

Ambey Laboratories Technicals

EMA & SMA

Current Price
₹64.80
+ 3.25 (5.28%)
pointer
  • stock-down_img
  • Bullish Moving Average 1
  • stock-up_img
  • Bearish Moving Average 12
  • 20 Day
  • ₹66.91
  • 50 Day
  • ₹66.14
  • 100 Day
  • ₹68.55
  • 200 Day
  • -

Resistance and Support

65.05 Pivot Speed
  • R3 70.10
  • R2 68.50
  • R1 66.65
  • S1 63.20
  • S2 61.60
  • S3 59.75

What's your outlook on Ambey Laboratories?

You can only vote for once

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Ambey Laboratories Ltd has an operating revenue of Rs. 391.63 Cr. on a trailing 12-month basis. An annual revenue growth of 14% is good, Pre-tax margin of 5% is okay, ROE of 36% is exceptional. The company has a debt to equity of 78%, which is bit higher. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 56 which is a POOR score indicating inconsistency in earnings, a RS Rating of 7 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B+ which is evident from recent demand for the stock, Group Rank of 71 indicates it belongs to a poor industry group of Diversified Operations and a Master Score of E is the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Ambey Laboratories Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-11-13 Quarterly Results
2024-10-22 To consider Fund Raising
2024-10-09 Others To consider Fund Raising and other business matters.

Ambey Laboratories F&O

Ambey Laboratories Shareholding Pattern

69.9%
1.46%
0.1%
20.28%
8.26%

About Ambey Laboratories

  • NSE Symbol
  • AMBEY
  • BSE Symbol
  • ISIN
  • INE0M3I01029

Similar Stocks to Ambey Laboratories

Ambey Laboratories FAQs

Ambey Laboratories share price is ₹64 As on 22 December, 2024 | 22:09

The Market Cap of Ambey Laboratories is ₹161.7 Cr As on 22 December, 2024 | 22:09

The P/E ratio of Ambey Laboratories is As on 22 December, 2024 | 22:09

The PB ratio of Ambey Laboratories is 7.7 As on 22 December, 2024 | 22:09

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23